Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000806566 | SCV000946570 | pathogenic | Familial hypercholesterolemia | 2018-08-06 | criteria provided, single submitter | clinical testing | This variant is an in-frame deletion of the genomic region encompassing exons 2-6 of the LDLR gene. It preserves the integrity of the reading frame. A similar deletion of exons 2-6 has been reported in individuals affected with familial hypercholesterolemia (PMID: 1319734, 2837085, 22883975). Variants that disrupt the p.Asp90 amino acid residue in LDLR have been observed in affected individuals (PMID: 25962062, 21376320, 27765764, 15823276, 16343504, 12837857). This suggests that it is a clinically significant residue, and that other variants that disrupt this residue are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic. |